Member Exclusive

CRISPR-Cas9 gene-editing: can it be used to identify therapeutic targets for ALS?

Genome-wide gene-knockout screens using CRISPR-Cas9 could allow researchers to identify potential drug targets for amyotrophic lateral sclerosis and other neurodegenerative diseases.

Go to the profile of Hannah Makin
Mar 09, 2018
0
0

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.